Samsung Medical Center: Carcinoma, Hepatocellular trials

The registry lists 16 Carcinoma, Hepatocellular studies with Samsung Medical Center as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 7Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver CancerRecruitingNCT07884877Phase 2
• Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of SorafenibCompletedNCT03163992Phase 2Results posted
• Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein InvasionCompletedNCT05625893Phase 2
• The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin ResistanceTerminatedNCT04649671Not applicable
• Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor ThrombosisCompletedNCT02571946Not applicable
• Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic ResectionCompletedNCT02329821
• Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal LoadStatus unknownNCT02308319Phase 4
• Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT02290977Phase 2
• Diffusion-Weighted Magnetic Resonance ImagingStatus unknownNCT02242786Phase 2
• to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)CompletedNCT02008929Phase 2
• Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor ThrombosisCompletedNCT01911000Phase 2
• Stereotactic Body Radiotherapy for Unresectable Hepatocellular CarcinomaCompletedNCT01910909Not applicable
• Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular CarcinomaCompletedNCT01506115Not applicable
• Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell CarcinomaCompletedNCT01482520
• Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma PatientsCompletedNCT01481805
• Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular CarcinomaCompletedNCT01131689Phase 1